Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: KonKilo who wrote (10331)	1/22/2003 5:04:15 PM
From: Bucky Katt	Respond to of 48461

Nice with RAPT....XTRN Announces the Retention of West Ridge Associates Wednesday January 22, 4:35 pm ET Talk about a sorry biorat, this is it. Maybe things will start changing. BROOMFIELD, Colo.--(BUSINESS WIRE)--Jan. 22, 2003--Xtrana, Inc. (OTCBB: XTRN - News) announced today that it has retained the investment banking firm of West Ridge Associates, LLC of Los Angeles, California, to advise the Board of Directors with regard to strategic alternatives for the Company. "Over the past several months, the Board has considered various alternatives to protect and maximize shareholder value and to realize the potential for Xtrana's outstanding technologies," said Tim Dahltorp, Xtrana's CEO. "The Board has retained West Ridge to advise them on these alternatives, and to assist them in their execution." West Ridge Associates, LLC provides merger and acquisition, corporate finance, business valuation and related investment banking services to established middle market and earlier stage companies with high growth potential. The firm specializes in the representation of life science companies. For additional information please visit www.west-ridge.com. Xtrana, Inc. develops, manufactures and markets novel nucleic acid extraction kits and detection systems for use in molecular diagnostics, drug discovery, forensics, research, clinical and life sciences markets. To learn more about Xtrana, visit the Company's web site at www.xtrana.com.